SCHEMBL8196837

SCHEMBL8196837

CSc1ccc(-c2ccc3oc(-c4ccccc4C4=NCCN4)cc3c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 12/20 0.51
ALDH1A1 P00352 3/20 0.51
CYP1A2 P05177 3/20 0.51
HSD17B10 Q99714 3/20 0.51
CYP2D6 P10635 2/20 0.51
USP2 O75604 1/20 0.51
POLB P06746 1/20 0.51
CYP3A4 P08684 1/20 0.51
MAPT P10636 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
RECQL P46063 1/20 0.51
BLM P54132 1/20 0.51
UBE2N P61088 1/20 0.51
KMT2A Q03164 1/20 0.51
FTO Q9C0B1 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
HPGD P15428 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ADRA2A P08913 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8198114 0.89 NISCH (0.54) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8194569 0.89 NISCH (0.56) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
Hydrochloric Acid SCHEMBL7736746 0.88 NISCH (0.62) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8196630 0.86 NISCH (0.53) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8199412 0.85 NISCH (0.52) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8200670 0.84 NISCH (0.53) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
Hydrochloric Acid SCHEMBL8199821 0.82 NISCH (0.50) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
Hydrochloric Acid SCHEMBL8188726 0.82 NISCH (0.50) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8201878 0.82 NISCH (0.51) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8198751 0.82 NISCH (0.54) NISCHALDH1A1CYP1A2HSD17B10CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 WO disclosed